Himadri Speciality Chemical Limited (BOM:500184)
India · Delayed Price · Currency is INR 452.25
-3.05 (-0.67%)
At close: Feb 12, 2026
BOM:500184 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 45,076 | 46,126 | 41,849 | 41,718 | 27,913 | 16,795 |
| 45,076 | 46,126 | 41,849 | 41,718 | 27,913 | 16,795 | |
Revenue Growth (YoY) | -3.17% | 10.22% | 0.31% | 49.46% | 66.20% | -7.00% |
Cost of Revenue | 28,883 | 31,783 | 30,681 | 32,964 | 22,801 | 12,563 |
Gross Profit | 16,193 | 14,344 | 11,168 | 8,754 | 5,112 | 4,232 |
Selling, General & Admin | 2,087 | 1,668 | 1,271 | 969.9 | 841.91 | 801.95 |
Other Operating Expenses | 4,538 | 4,208 | 3,541 | 3,585 | 2,632 | 2,112 |
Operating Expenses | 7,258 | 6,426 | 5,311 | 5,063 | 3,969 | 3,384 |
Operating Income | 8,935 | 7,918 | 5,857 | 3,690 | 1,142 | 848.17 |
Interest Expense | -517.99 | -408.29 | -577.99 | -624.79 | -314.99 | -315.76 |
Interest & Investment Income | 438.96 | 438.96 | 361.54 | 175.79 | 27.5 | 46.45 |
Currency Exchange Gain (Loss) | -52.32 | 53.78 | 65.65 | -198.01 | -68.11 | 52.12 |
Other Non Operating Income (Expenses) | 732.03 | 21.73 | -0.52 | 9.66 | -15.51 | 0.78 |
EBT Excluding Unusual Items | 9,536 | 8,024 | 5,706 | 3,053 | 771.13 | 631.75 |
Gain (Loss) on Sale of Investments | 35.85 | 35.85 | 20.82 | 14.32 | - | 0.93 |
Asset Writedown | - | - | - | - | -246.51 | - |
Other Unusual Items | - | - | - | -300 | - | - |
Pretax Income | 9,574 | 8,062 | 5,739 | 2,802 | 534.65 | 645.61 |
Income Tax Expense | 2,544 | 2,511 | 1,632 | 643.91 | 144.11 | 172.95 |
Earnings From Continuing Operations | 7,030 | 5,551 | 4,107 | 2,159 | 390.55 | 472.66 |
Minority Interest in Earnings | 31.34 | 5.34 | 0.9 | 1.18 | 18.92 | 2.11 |
Net Income | 7,061 | 5,556 | 4,108 | 2,160 | 409.47 | 474.78 |
Net Income to Common | 7,061 | 5,556 | 4,108 | 2,160 | 409.47 | 474.78 |
Net Income Growth | 37.06% | 35.27% | 90.19% | 427.46% | -13.76% | -76.89% |
Shares Outstanding (Basic) | 496 | 494 | 448 | 421 | 419 | 419 |
Shares Outstanding (Diluted) | 499 | 497 | 449 | 421 | 419 | 419 |
Shares Change (YoY) | 1.15% | 10.84% | 6.58% | 0.46% | 0.04% | 0.04% |
EPS (Basic) | 14.25 | 11.26 | 9.16 | 5.13 | 0.98 | 1.13 |
EPS (Diluted) | 14.16 | 11.17 | 9.16 | 5.13 | 0.98 | 1.13 |
EPS Growth | 35.42% | 21.94% | 78.56% | 424.90% | -13.51% | -76.98% |
Free Cash Flow | - | 2,763 | 3,524 | -285.61 | 3,077 | -754.19 |
Free Cash Flow Per Share | - | 5.56 | 7.86 | -0.68 | 7.34 | -1.80 |
Dividend Per Share | - | 0.600 | 0.500 | 0.250 | 0.200 | 0.150 |
Dividend Growth | - | 20.00% | 100.00% | 25.00% | 33.33% | - |
Gross Margin | 35.92% | 31.10% | 26.69% | 20.98% | 18.31% | 25.20% |
Operating Margin | 19.82% | 17.17% | 14.00% | 8.85% | 4.09% | 5.05% |
Profit Margin | 15.67% | 12.05% | 9.82% | 5.18% | 1.47% | 2.83% |
Free Cash Flow Margin | - | 5.99% | 8.42% | -0.69% | 11.02% | -4.49% |
EBITDA | 9,478 | 8,427 | 6,322 | 4,148 | 1,583 | 1,276 |
EBITDA Margin | 21.03% | 18.27% | 15.11% | 9.94% | 5.67% | 7.60% |
D&A For EBITDA | 543.09 | 509.49 | 464.69 | 457.48 | 440.56 | 427.71 |
EBIT | 8,935 | 7,918 | 5,857 | 3,690 | 1,142 | 848.17 |
EBIT Margin | 19.82% | 17.17% | 14.00% | 8.85% | 4.09% | 5.05% |
Effective Tax Rate | 26.57% | 31.14% | 28.43% | 22.98% | 26.95% | 26.79% |
Revenue as Reported | 46,303 | 46,643 | 42,274 | 41,998 | 27,985 | 16,935 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.